Karin Yoo

Karin Yoo is an associate in the firm’s Business Law department and a member of its nationally recognized Life Sciences group. Karin represents clients across the biotechnology, pharmaceutical and life sciences industries, including public and private companies and investment banks, throughout the full range of the corporate life cycle, and has worked with many of her issuer-side clients since their initial founding and funding.

Karin advises public and private companies on startup and formation matters, venture capital financings, strategic investments and capital markets transactions, including initial public offerings, follow-on public offerings, ATMs and PIPEs, as well as other complex transactions. She also represents publicly traded biotechnology companies in ongoing corporate matters, including SEC and securities law compliance and corporate governance matters. She joined Goodwin in 2018.

While in law school, Karin served as a staff editor of the Boston College Law & Religion Review and the Boston College Intellectual Property and Technology Forum. She was a summer associate at a prominent employment litigation law firm in Boston. In 2017, Karin worked as an honors legal intern in the Asset Management Unit of the Enforcement Division at the U.S. Securities and Exchange Commission in New York.

Karin is a member of the Boston and American Bar Associations. 

Karin was a Public Interest Designation Fellow and was a recipient of a Pro Bono Excellence Award at Boston College Law School.